Immucell (ICCC) EBIT (QoQ) (2010 - 2025)
Powered by 
Analysis
Immucell (ICCC) EBIT (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -388.70% |
| Sep 30, 2025 | -96.48% |
| Jun 30, 2025 | -49.04% |
| Mar 31, 2025 | 79.86% |
| Dec 31, 2024 | 208.09% |
| Sep 30, 2024 | 58.54% |
| Jun 30, 2024 | -362.12% |
| Sep 30, 2023 | 9.23% |
| Jun 30, 2023 | 42.18% |
| Mar 31, 2023 | -38.09% |
| Dec 31, 2022 | -164.88% |
| Sep 30, 2022 | 0.36% |
| Jun 30, 2022 | -208.48% |
| Mar 31, 2022 | 292.41% |
| Dec 31, 2021 | -46.36% |
| Sep 30, 2021 | 25.79% |
| Jun 30, 2021 | 157.53% |
| Mar 31, 2021 | 40.94% |
| Dec 31, 2020 | -152.13% |
| Sep 30, 2020 | 63.60% |